Deep Learning Signature for Predicting Complete Pathological Response to Neoadjuvant Chemoimmunotherapy in Non-small Cell Lung Cancer
Condition(s):Non-small Cell Lung Cancer; Neoadjuvant Chemoimmunotherapy; Complete Pathological ResponseLast Updated:June 29, 2023Recruiting